Clinical Validation of NAVOY® Acute Kidney Injury in Swedish ICU Patients

The study aims to evaluate the performance of the prediction algorithm NAVOY® AKI in a Swedish adult ICU patient population versus fulfilment of KDIGO diagnostic criteria.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Kidney Injury Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Intensiv- och perioperativ vård

Malmö, 20502, Sweden

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The study will only include the subjects from the SEP-SE-02 study population. (NCT04570618)

Exclusion criteria

None

Treatment and study plan

Primary outcomes

Prediction performance of NAVOY® AKI

Time frame: Data from ICU stay between December 2020 to October 2021.

The sensitivity, specificity, and accuracy will be calculated comparing the algorithm's predictions with the true AKI outcome.

Sponsors and collaborators

Lead sponsor

AlgoDx

Industry

Registry information

Acronym: ExTRACT

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Jun 21, 2022
Registry last updated: Dec 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed